Race affects insulin and GLP-1 secretion and response to a long-acting somatostatin analogue in obese adults
Open Access
- 6 January 2004
- journal article
- clinical trial
- Published by Springer Nature in International Journal of Obesity
- Vol. 28 (2) , 330-333
- https://doi.org/10.1038/sj.ijo.0802561
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neuronsJournal of Clinical Investigation, 2002
- The role of postprandial releases of insulin and incretin hormones in meal-induced satiety—effect of obesity and weight reductionInternational Journal of Obesity, 2001
- GIF biology and fat metabolismLife Sciences, 1999
- Rapid Identification of Subtype-Selective Agonists of the Somatostatin Receptor Through Combinatorial ChemistryScience, 1998
- Glucagon-like peptide-1 binding to rat skeletal musclePeptides, 1995
- Tissue‐specific expression of the human receptor for glucagon‐like peptide‐I: brain, heart and pancreatic forms have the same deduced amino acid sequencesFEBS Letters, 1995
- Low-dose octreotide is able to cause a maximal inhibition of the glycemic responses to a mixed meal in obese type 2 diabetic patients treated with insulinDiabetes Research and Clinical Practice, 1991
- Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7–36) amide, on fatty acid synthesis in explants of rat adipose tissueJournal of Endocrinology, 1991
- Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intoleranceEuropean Journal of Clinical Investigation, 1979
- Inhibition of actions of glucagon in adipocytes by gastric inhibitory polypeptideMetabolism, 1976